DODGX
Price
$17.44
Change
+$0.11 (+0.63%)
Updated
Jul 24 closing price
Net Assets
118.33B
TWQIX
Price
$19.48
Change
+$0.10 (+0.52%)
Updated
Jul 24 closing price
Net Assets
2.64B
Interact to see
Advertisement

DODGX vs TWQIX

DODGX vs TWQIX Comparison Chart in %
View a ticker or compare two or three
VS
DODGX vs. TWQIX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a Buy and TWQIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 118B vs. TWQIX (2.64B). DODGX pays higher dividends than TWQIX: DODGX (1.10) vs TWQIX (0.72). DODGX was incepted earlier than TWQIX: DODGX (62 years) vs TWQIX (16 years). TWQIX (0.72) is less costly to investors than DODGX (0.51). TWQIX is a more actively managed with annual turnover of: 25.00 vs. DODGX (20.00). DODGX has a lower initial minimum investment than TWQIX: DODGX (2500) vs TWQIX (1000000). TWQIX annual gain was more profitable for investors over the last year : 21.58 vs. DODGX (8.21). DODGX return over 5 years is better than : 158.60 vs. TWQIX (52.41).
DODGXTWQIXDODGX / TWQIX
Total Expense Ratio0.510.6381%
Annual Report Gross Expense Ratio0.510.7271%
Fund Existence62 years16 years-
Gain YTD5.79212.87145%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets118B2.64B4,470%
Annual Yield % from dividends1.100.72153%
Returns for 1 year8.2121.5838%
Returns for 3 years104.2551.59202%
Returns for 5 years158.6052.41303%
Returns for 10 years470.0367.57696%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LRSPX15.050.03
+0.20%
Lord Abbett Small Cap Value P
SQBIX16.480.01
+0.06%
X-Square Balanced Fund, LLC Instl
BARIX92.93N/A
N/A
Baron Asset Instl
FFGGX42.24-0.01
-0.02%
American Funds Global Balanced 529-F-2
FBDIX194.82-0.70
-0.36%
Franklin Biotechnology Discovery A